Abbott and Johnson & Johnson both put forward separate clinical studies for their platforms for coronary intravascular lithotripsy, or IVL, designed to break through hardened plaque in the arteries feeding the heart muscle. Both trials … [Read More...] about Abbott, J&J spotlight clinical successes in coronary intravascular lithotripsy
Main Content
Medical Tubing & Extrusion
Abbott, J&J spotlight clinical successes in coronary intravascular lithotripsy
Abbott and Johnson & Johnson both put forward separate clinical studies for their platforms for coronary intravascular lithotripsy, or IVL, designed to break through hardened plaque in the arteries feeding the heart muscle. Both trials … [Read More...] about Abbott, J&J spotlight clinical successes in coronary intravascular lithotripsy
Flow Medical raises $6M in round with strategic investors
Flow Medical has raised $6 million in a new funding round that includes two strategic medical device investors, the company tells MassDevice. The Chicago-based startup is developing the investigational HELYX-PE System, a next-gen catheter-directed … [Read More...] about Flow Medical raises $6M in round with strategic investors
BD begins US rollout of next-gen liver stent graft
BD (NYSE: BDX) is rolling out a new minimally invasive implant to the U.S. designed to help relieve high blood pressure within the liver, placed through a transjugular intrahepatic portosystemic shunt procedure — or TIPS for short. The Liverty … [Read More...] about BD begins US rollout of next-gen liver stent graft
Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold
The Teleflex (NYSE: TFX) Freesolve RMS (resorbable magnesium scaffold) has won FDA Breakthrough Device designation for percutaneous coronary intervention (PCI). "Freesolve RMS has the potential to provide physicians with an additional treatment … [Read More...] about Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold
J&J launches faster Shockwave coronary catheter in the US
Johnson & Johnson (NYSE: JNJ) is launching the latest version of its intravascular lithotripsy catheter for cracking calcium within the coronary arteries, which the company said it designed to cut treatment times in half. The Shockwave C2 Aero … [Read More...] about J&J launches faster Shockwave coronary catheter in the US
Haemonetics wins FDA approval of PerQseal Elite vascular closure system
Haemonetics (NYSE: HAE) has received FDA approval for its PerQseal Elite vascular closure system for large-bore arterial procedures, following the company's $116.4 million acquisition of Vivasure Medical in January 2026. The FDA approval, … [Read More...] about Haemonetics wins FDA approval of PerQseal Elite vascular closure system
E2’s pulmonary embolism platform claims two FDA clearances
Endovascular Engineering (E2) has received a pair of FDA clearances for its pulmonary embolism treatment platform, spanning its dual-action thrombectomy system and hardware that returns filtered blood to the patient. The Hēlo system combines … [Read More...] about E2’s pulmonary embolism platform claims two FDA clearances
